Zylet Bausch & Lomb - Treatment for Inflammatory Ocular Conditions
Zylet is a corticosteroid and antibiotic combination for the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of infection exists. Zylet will be available in the United States early in the first quarter of 2005.Posted: December 2004
Related Articles:
- FDA Issues Approvable Letter to Bausch & Lomb for Ophthalmic Anti-inflammatory/Antibiotic Combination Product - August 9, 2004
